Trial Search Results

SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay

The purpose of this study is to evaluate the performance of the Karius Infectious Diseases Plasma Sequencing Assay in patients who present to the emergency room with sepsis.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Karius, Inc.

Collaborator: Stanford University

Stanford Investigator(s):


Inclusion Criteria:

   1. 18 years or older

   2. Meet 2 of 4 sepsis criteria

      1. Temperature > 38C or < 36C

      2. Heart rate > 90 bpm

      3. Respiratory rate >20 or PaCO2 <32mmHg

      4. WBC >12000/µL or < 4000/µL or > 10% bands

Exclusion Criteria:

   1. Inability to understand instructions and comply with study-related procedures

   2. Any condition that in the opinion of the treating physician will prevent the subject
   from completing the study.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting